CompletedNot applicableNCT02013297
Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)
Studying Ependymoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Leon Berard
- Principal Investigator
- Line CLAUDE, DoctorCentre Leon Berard
- Intervention
- SBRT treatment(radiation)
- Enrollment
- 61 enrolled
- Eligibility
- 20 years · All sexes
- Timeline
- 2013 – 2021
Study locations (15)
- Centre Antoine Lacassagne, Nice, Alpes Maritimes, France
- Centre Paul Strauss, Strasbourg, Bas-Rhin, France
- Hôpital La Timone, Marseille, Bouches Du Rhône, France
- Centre François Baclesse, Caen, Calvados, France
- CHU Bordeaux - Hôpital Saint André, Bordeaux, Gironde, France
- Centre Claudius Régaud, Toulouse, Haute Garonne, France
- Institut de Cancérologie de Montpellier, Montpellier, Hérault, France
- Centre Eugène Marquis, Rennes, Ille Et Vilaine, France
- CHRU de Tours - Hôpital Bretonneau, Tours, Indre Et Loire, France
- Institut de Cancérologie de l'Ouest René Gauducheau, Saint-Herblain, Loire Atlantique, France
- Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, Meurthe Et Moselle, France
- Centre Oscar Lambret, Lille, Nord, France
- Centre Léon Bérard, Lyon, Rhône, France
- Institut Gustave Roussy, Villejuif, Val De Marne, France
- Institut Curie, Paris, Île-de-France Region, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02013297 on ClinicalTrials.govOther trials for Ependymoma
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1NCT04903080HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With EpendymomaChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE2NCT04743661131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaPediatric Brain Tumor Consortium
- RECRUITINGPHASE1NCT05106296Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerTheodore S. Johnson
- RECRUITINGNCT05151718Multiomic Approach to Radioresistance of Ependymomas in Children and AdolescentsInstitut Claudius Regaud
- ACTIVE NOT RECRUITINGPHASE1NCT04661384Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or MedulloblastomaCity of Hope Medical Center
- ACTIVE NOT RECRUITINGPHASE1NCT02774421Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent EpendymomaUniversity of Colorado, Denver
- RECRUITINGPHASE2, PHASE3NCT02265770An International Clinical Program for the Diagnosis and Treatment of Children With EpendymomaCentre Leon Berard
- ACTIVE NOT RECRUITINGPHASE2NCT02125786A Trial of Surgery and Fractionated Re-Irradiation for Recurrent EpendymomaSt. Jude Children's Research Hospital